Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome

Clinical Endocrinology

Volumn 83, Issue 1, 2015, Pages 98-104

  Olszanecka Glinianowicz, Magdalena ^a   Madej, Paweł ^a   Owczarek, Aleksander ^a   Chudek, Jerzy ^a   Skałba, Piotr ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANDROGEN; APELIN; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; OMENTIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ADIPOQ PROTEIN, HUMAN; APLN PROTEIN, HUMAN; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; SEX HORMONE BINDING GLOBULIN; SIGNAL PEPTIDE;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; OBESITY; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; CASE CONTROL STUDY; COMPLICATION; METABOLISM; YOUNG ADULT;

ADIPOKINES; ADIPONECTIN; ADULT; ANDROGENS; ANTI-MULLERIAN HORMONE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; FOLLICLE STIMULATING HORMONE; GPI-LINKED PROTEINS; HUMANS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LECTINS; LEPTIN; LUTEINIZING HORMONE; NUTRITIONAL STATUS; OBESITY; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN; YOUNG ADULT;

EID: 84932199528     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12687     Document Type: Article

References (37)

1. Baarends, W.M., Uilenbroek, J.T., Kramer, P., et al,. (1995) Anti-mullerian hormone and anti-mullerian type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology, 136, 4951-4962.
2. Weerakiet, S., Lertvikool, S., Tingthanatikul, Y., et al,. (2007) Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling. Gynecological Endocrinology, 23, 455-460.
3. Milewicz, T., Krzysiek, J., Blakała, B., et al,. (2007) Clomiphene citrate challenge test and serum anti-Müllerian hormone levels in women with menstrual irregularities and/or infertility. Folia Histochemica Cytobiologica, 45 (Suppl. 1), S119-S121.
4. Nardo, L.G., Christodoulou, D., Gould, D., et al,. (2007) Anti-Müllerian hormone levels and antral follicle count in women enrolled in vitro fertilization cycles: relationship to lifestyle factors, chronological age and reproductive history. Gynecological Endocrinology, 23, 486-493.
5. Fanchin, R., Schonäuer, L.M., Righini, C., et al,. (2003) Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Human Reproduction, 18, 328-332.
6. de Vet, A., Laven, J.S., de Jong, F.H., et al,. (2002) Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertility and Sterility, 77, 357-362.
7. Lie Fong, S., Visser, J.A., Welt, C.K., et al,. (2012) Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. The Journal of Clinical Endocrinology and Metabolism, 97, 4650-4655.
8. Piltonen, T., Morin-Papunen, L., Koivunen, R., et al,. (2005) Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Human Reproduction, 20, 1820-1826.
9. Pellatt, L., Hanna, L., Brincat, M., et al,. (2007) Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. The Journal of Clinical Endocrinology and Metabolism, 92, 240-245.
10. Fanchin, R., Schonauer, L.M., Righini, C., et al,. (2003) Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Human Reproduction, 18, 323-327.
11. Freeman, E.W., Gracia, C.R., Sammel, M.D., et al,. (2007) Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertility and Sterility, 87, 101-106.
12. Gracia, C.R., Freeman, E.W., Sammel, M.D., et al,. (2005) The relationship between obesity and race on inhibin B during the menopause transition. Menopause, 12, 559-566.
13. Fedorcsak, P., Dale, P.O., Storeng, R., et al,. (2004) Impact of overweight and underweight on assisted reproduction treatment. Human Reproduction, 19, 2523-2528.
14. Rich-Edwards, J.W., Spiegelman, D., Garland, M., et al,. (2002) Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology, 13, 184-190.
15. Wang, J.X., Davies, M., &, Norman, R.J., (2000) Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. British Medical Journal, 321, 1320-1321.
16. Spandorfer, S.D., Kump, L., Goldschlag, D., et al,. (2004) Obesity and in vitro fertilization: negative influences on outcome. The Journal of Reproductive Medicine, 49, 973-977.
17. Wittemer, C., Ohl, J., Bailly, M., et al,. (2000) Does body mass index of infertile women have an impact on IVF procedure and outcome? Journal of Assisted Reproduction and Genetics, 17, 547-552.
18. Su, H.I., Sammel, M.D., Freeman, E.W., et al,. (2008) Body size affects measures of ovarian reserve in late reproductive age women. Menopause, 15, 857-861.
19. Sahmay, S., Usta, T., Erel, C.T., et al,. (2012) Is there any correlation between AMH and obesity in premenopausal women? Archives of Gynecology and Obstetrics, 286, 661-665.
20. Halawaty, S., ElKattan, E., Azab, H., et al,. (2010) Effect of obesity on parameters of ovarian reserve in premenopausal women. Journal of Obstetrics and Gynaecology Canada, 32, 687-690.
21. Chen, M.J., Yang, W.S., Chen, C.L., et al,. (2008) The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Human Reproduction, 23, 952-957.
22. Piouka, A., Farmakiotis, D., Katsikis, I., et al,. (2009) Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. American Journal of Physiology Endocrinology Metabolism, 296, E238-E243.
23. Hwang, Y.I., Sung, N.Y., Koo, H.S., et al,. (2013) Can high serum anti-Müllerian hormone levels predict the phenotypes of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients? Clinical and Experimental Reproductive Medicine, 40, 135-140.
24. Cook, C.L., Siow, Y., Brenner, A.G., et al,. (2002) Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertility and Sterility, 77, 141-146.
25. Pigny, P., Merlen, E., Robert, Y., et al,. (2003) Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. The Journal of Clinical Endocrinology and Metabolism, 88, 5957-5962.
26. La Marca, A., Orvieto, R., Giulini, S., et al,. (2004) Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertility and Sterility, 82, 970-972.
27. Laven, J.S., Mulders, A.G., Visser, J.A., et al,. (2004) Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. The Journal of Clinical Endocrinology and Metabolism, 89, 318-323.
28. Skałba, P., Cygal, A., Madej, P., et al,. (2011) Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome? European Journal Obstetrics Gynecology and Reproductive Biology, 158, 254-259.
29. Li, Y., Ma, Y., Chen, X., et al,. (2012) Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism. Journal of Assisted Reproduction and Genetics, 29, 1147-1151.
30. Merhi, Z., Buyuk, E., Berger, D.S., et al,. (2013) Leptin suppresses anti-Mullerian hormone gene expression through the JAK2/STAT3 pathway in luteinized granulosa cells of women undergoing IVF. Human Reproduction, 28, 1661-1669.
31. Park, H.T., Cho, G.J., Ahn, K.H., et al,. (2010) Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). Clinical Endocrinology (Oxford), 72, 26-31.
32. Olszanecka-Glinianowicz, M., Kuglin, D., Dąbkowska-Huc, A., et al,. (2011) Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. European Journal Obstetrics Gynecology and Reproductive Biology, 154, 51-56.
33. Olszanecka-Glinianowicz, M., Madej, P., Nylec, M., et al,. (2013) Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances. Clinical Endocrinology (Oxford), 79, 238-242.
34. Orlik, B., Madej, P., Owczarek, A., et al,. (2014) Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome. Clinical Endocrinology (Oxford), 81, 529-535.
35. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19, 41-47.
36. Pigny, P., Cortet-Rudelli, C., Decanter, C., et al,. (2000) Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism. Fertility and Sterility, 73, 972-977.
37. Cortet-Rudelli, C., Pigny, P., Decanter, C., et al,. (2002) Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome. Fertility and Sterility, 77, 281-287.